Morgan Stanley Maintains Overweight on Exelon, Raises Price Target to $74
Morgan Stanley analyst Stephen Byrd maintains Exelon (NASDAQ:EXC) with a Overweight and raises the price target from $69 to $74.
Analyst Ratings For Exelon
Exelon (NASDAQ:EXC) has observed the following analyst ratings within the last quarter:
10 Biggest Price Target Changes For Monday
Wells Fargo cut the price target on Ross Stores, Inc. (NASDAQ: ROST) from $135 to $120. Ross Stores shares fell 0.4% to $113.80 in pre-market trading.
Mizuho Downgrades Exelon to Neutral, Raises Price Target to $57
Mizuho analyst Paul Fremont downgrades Exelon (NASDAQ:EXC) from Buy to Neutral and raises the price target from $55 to $57.
Jim Cramer Believes These Stocks Are ‘Terrific’
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he believes Exelon Corporation (NYSE: EXC) is terrific. "I could tell you it’s a couple of bucks ahead of itself, but I think you’ve got a winner there," he added.
New York Public Service Commission Approves Exelon Separation
Exelon Corp. (NASDAQ:EXC) announced today that the New York State Public Service Commission has approved a unanimous settlement agreement that allows Exelon to move forward with its plan to separate into two companies in the first quarter of 2022.
Earnings Scheduled For November 3, 2021
Companies Reporting Before The Bell
• R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.
If You Invested $100 Over The Past 20 Years In This Dividend Stock, Here’s How Much You Would Have Today
Exelon (NASDAQ:EXC) has outperformed the market over the past 90 days by 8.52%, generating a 12.49% return for its investors over the time period. Now, given this information, it may seem like price appreciation alone is the best way to have made money on this stock, that's not actually the case.
Expert Ratings For Exelon
Exelon (NASDAQ:EXC) has observed the following analyst ratings within the last quarter:
Wells Fargo Maintains Overweight on Exelon, Raises Price Target to $62
Wells Fargo analyst Neil Kalton maintains Exelon (NASDAQ:EXC) with a Overweight and raises the price target from $58 to $62.